iifl-logo

Fredun Pharmaceuticals Ltd Share Price Live

Add as a Preferred Source on Google
₹2,610.15
(3.06%)
Jun 17, 2026|05:30:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

  • Open₹2,540
  • Day's High₹2,699
  • 52 Wk High₹2,620
  • Prev. Close₹2,532.75
  • Day's Low₹2,539.95
  • 52 Wk Low ₹791
  • Turnover (lac)410.44
  • P/E43.33
  • Face Value₹10
  • Book Value₹489.43
  • EPS60.24
  • Mkt. Cap (Cr.)₹1,438.89
  • Div. Yield0.03
View All Historical Data

No Record Found

No Record Found

Fredun Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹2,540

Prev. Close

₹2,532.75

Turnover(Lac.)

₹410.44

Day's High

₹2,699

Day's Low

₹2,539.95

52 Week's High

₹2,620

52 Week's Low

₹791

Book Value

₹489.43

Face Value

₹10

Mkt Cap (₹ Cr.)

1,438.89

P/E

43.33

EPS

60.24

Divi. Yield

0.03

Fredun Pharmaceuticals Ltd Corporate Action

15 Sep 2025

12:00 AM

AGM

Announcement Date: 15 Sep, 2025

arrow

20 Jan 2026

12:00 AM

BookCloser

arrow

15 May 2026

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

31 May 2025

12:00 AM

Dividend

Dividend Amount: 0.7

Record Date: 23 Sep, 2025

arrow

19 Jan 2026

12:00 AM

EGM

arrow

Fredun Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Knowledge Center

Demat Account

View More

Trading Account

View More

Fredun Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

17 Jun, 2026|02:52 AM
Mar-2026Mar-2026Feb-2026Dec-2025
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 44.16%

Foreign: 0.00%

Indian: 44.16%

Non-Promoter- 3.90%

Institutions: 3.89%

Non-Institutions: 51.94%

Custodian: 0.00%

Read More
Share PriceShare Price

Fredun Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2026Mar-2025Mar-2024Mar-2023

Equity Capital

19.37

4.72

6.27

12.86

Preference Capital

0

0

0

0

Reserves

259.33

136.68

115.2

83.52

Net Worth

278.7

141.4

121.47

96.38

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

133.89

112.77

58.06

56.69

yoy growth (%)

18.72

94.2

2.41

33.96

Raw materials

-101.77

-80.14

-39.51

-37.17

As % of sales

76

71.06

68.04

65.57

Employee costs

-8.65

-8.94

-5.18

-4.91

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

4.37

2.49

2.64

2.22

Depreciation

-2

-1.87

-1.28

-1.13

Tax paid

-1.19

-0.59

-0.89

-0.79

Working capital

7.41

38.35

2.4

0.25

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

18.72

94.2

2.41

33.96

Op profit growth

10.51

95.94

27.02

-14.89

EBIT growth

23.5

50.86

11.66

3.5

Net profit growth

5.92

8.62

22.66

33.46

View Ratios
Particulars (Rupees in Crores.)Mar-2026Mar-2025

Gross Sales

633.33

451.71

Excise Duty

0

0

Net Sales

633.33

451.71

Other Operating Income

5.8

4.56

Other Income

0

0

Fredun Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,819.95

145.484,36,666.97608.70.884,887.2793.23

Divis Laboratories Ltd

DIVISLAB

6,660.1

66.411,76,804.737560.452,793629.49

Torrent Pharmaceuticals Ltd

TORNTPHARM

4,448.4

68.051,50,554.074670.852,677249.73

Cipla Ltd

CIPLA

1,350.75

31.71,09,119.71384.640.963,840.92423.36

Zydus Lifesciences Ltd

ZYDUSLIFE

1,061.5

28.921,06,811.741,7220.093,564.6235.25

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Fredun Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Chairman / Executive Director / Joint MD

Daulat N Medhora

Executive Director / Managing Director / CFO

Fredun N Medhora

Independent Non Exe. Director

Daisy Dsouza

Independent Non Exe. Director

Anshu Agarwal

Independent Non Exe. Director

Sonal Desai

Independent Non Exe. Director

Pooja Narendra Sanghavi

Company Sec. & Compli. Officer

Vaishnavi Rajkamal Sahu

Registered Office

26 Manoj Industrial Premises,

G D Ambedkar Marg Wadala,

Maharashtra - 400031

Tel: 91-22-40318111

Website: http://www.fredungroup.com

Email: business@fredungroup.com

Registrar Office

9 ShivShakti Indl Es,

J R Boricha Marg, Lower Parel,

Mumbai - 400 011

Tel: 022- 23016761 / 2301

Website: www.purvashare.com

Email: support@purvashare.com

Summary

Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals Limited (FPL) was converted into a public limited company in Mar.94. The Company was promoted by Nariman Medhora and Daulat N ...
Read More

Reports by Fredun Pharmaceuticals Ltd

Company FAQs

What is the Fredun Pharmaceuticals Ltd share price today?

The Fredun Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹2610.15 today.

What is the Market Cap of Fredun Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fredun Pharmaceuticals Ltd is ₹1438.89 Cr. as of 17 Jun ‘26

What is the PE and PB ratio of Fredun Pharmaceuticals Ltd?

The PE and PB ratios of Fredun Pharmaceuticals Ltd is 43.33 and 5.33 as of 17 Jun ‘26

What is the 52 Week High and Low of Fredun Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Fredun Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Fredun Pharmaceuticals Ltd is ₹791 and ₹2620 as of 17 Jun ‘26

What is the CAGR of Fredun Pharmaceuticals Ltd?

Fredun Pharmaceuticals Ltd's CAGR for 5 Years at 43.22%, 3 Years at 41.51%, 1 Year at 202.47%, 6 Month at 45.28%, 3 Month at 56.94% and 1 Month at 10.00%.

What is the shareholding pattern of Fredun Pharmaceuticals Ltd?

The shareholding pattern of Fredun Pharmaceuticals Ltd is as follows:
Promoters - 44.17 %
Institutions - 3.89 %
Public - 51.94 %

QUICKLINKS FOR Fredun Pharmaceuticals Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.